Pulsed Field Ablation for Atrial Fibrillation

Status:

Awaiting development

Technology type:

Device

Decision:

Prioritised

Prioritisation programme:

HealthTech

Rationale:

Pulsed-field ablation for atrial fibrillation (HTG755) was assessed in 2025 by NICE’s interventional procedures (IPG) committee. The procedure was recommended for use with standard arrangements. The evidence showed that it reduces atrial fibrillation and its symptoms and increases quality of life in the short term. The evidence also suggested that the procedure has no major safety concerns. 

However, despite the recency of the NICE guidance, IPGs do not make comparisons between alternative treatments, do not include assessments of cost effectiveness and do not make technology specific recommendations. Whilst the IPGs provide support to clinicians doing the intervention, further guidance including a technology specific assessment of cost effectiveness would benefit procurement teams when considering the adoption and use of the intervention. 

Email enquiries

If you have any queries please email HealthTech1@nice.org.uk

Timeline

Key events during the development of the guidance:

For further information on our processes and methods, please see our CHTE processes and methods manual